Can-Fite BioPharma Ltd. (CANF.TA)
ILA 1.6
(6.67%)
ILA 1.6
(6.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 USD | 53.49% |
| 2022 | -0.01 USD | 43.42% |
| 2021 | -0.02 USD | 44.79% |
| 2020 | -0.04 USD | 72.47% |
| 2019 | -0.15 USD | 11.76% |
| 2018 | -0.17 USD | -13.33% |
| 2017 | -0.15 USD | 40.0% |
| 2016 | -0.25 USD | -19.05% |
| 2015 | -0.21 USD | 40.0% |
| 2014 | -0.35 USD | 42.62% |
| 2013 | -0.61 ILS | -10.91% |
| 2012 | -0.55 USD | 23.61% |
| 2011 | -0.72 USD | -71.43% |
| 2010 | -0.42 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q4 | -0.00 USD | 21.43% |
| 2023 FY | - USD | 53.49% |
| 2023 Q2 | -0.00 USD | 30.0% |
| 2023 Q1 | -0.00 USD | 44.44% |
| 2023 Q3 | -0.00 USD | 0.0% |
| 2022 Q1 | -0.00 USD | 58.11% |
| 2022 FY | - USD | 43.42% |
| 2022 Q2 | -0.00 USD | 3.23% |
| 2022 Q3 | -0.00 USD | 0.0% |
| 2022 Q4 | -0.00 USD | -20.0% |
| 2021 FY | - USD | 44.79% |
| 2021 Q2 | -0.01 USD | -58.97% |
| 2021 Q1 | -0.00 USD | 61.39% |
| 2021 Q3 | -0.01 USD | 0.0% |
| 2021 Q4 | -0.01 USD | -19.35% |
| 2020 Q2 | -0.01 USD | 41.67% |
| 2020 FY | - USD | 72.47% |
| 2020 Q1 | -0.02 USD | -6.4% |
| 2020 Q4 | -0.01 USD | -80.36% |
| 2020 Q3 | -0.01 USD | 55.56% |
| 2019 FY | - USD | 11.76% |
| 2019 Q2 | -0.04 USD | -5.0% |
| 2019 Q3 | -0.03 USD | 32.86% |
| 2019 Q4 | -0.02 USD | 28.01% |
| 2019 Q1 | -0.04 USD | 55.95% |
| 2018 FY | - USD | -13.33% |
| 2018 Q4 | -0.09 USD | -2114.63% |
| 2018 Q3 | -0.00 USD | 86.9% |
| 2018 Q2 | -0.03 USD | 37.4% |
| 2018 Q1 | -0.05 USD | -48.37% |
| 2017 Q1 | -0.04 USD | 41.1% |
| 2017 FY | - USD | 40.0% |
| 2017 Q4 | -0.03 USD | -103.01% |
| 2017 Q3 | -0.02 USD | 72.56% |
| 2017 Q2 | -0.06 USD | -61.76% |
| 2016 Q3 | -0.08 USD | -73.08% |
| 2016 Q1 | -0.06 USD | -570.34% |
| 2016 Q2 | -0.05 USD | 12.97% |
| 2016 Q4 | -0.06 USD | 24.04% |
| 2016 FY | - USD | -19.05% |
| 2015 Q4 | 0.01 USD | 108.43% |
| 2015 Q1 | -0.02 USD | 83.93% |
| 2015 Q2 | -0.09 USD | -473.03% |
| 2015 Q3 | -0.14 USD | -60.73% |
| 2015 FY | - USD | 40.0% |
| 2014 Q2 | -0.10 USD | 9.09% |
| 2014 Q3 | -0.05 USD | 47.2% |
| 2014 FY | - USD | 42.62% |
| 2014 Q4 | -0.09 USD | -79.17% |
| 2014 Q1 | -0.11 USD | 54.17% |
| 2013 FY | - ILS | -10.91% |
| 2013 Q1 | -0.21 USD | 77.42% |
| 2013 Q4 | -0.24 USD | -140.0% |
| 2013 Q2 | -0.13 USD | 38.1% |
| 2013 Q3 | -0.10 USD | 23.08% |
| 2012 FY | - USD | 23.61% |
| 2012 Q4 | -0.93 USD | -720.0% |
| 2012 Q2 | -0.11 USD | -14.35% |
| 2012 Q1 | -0.10 USD | 69.94% |
| 2012 Q3 | 0.15 USD | 236.36% |
| 2011 Q1 | -0.14 USD | -7.69% |
| 2011 FY | - USD | -71.43% |
| 2011 Q2 | -0.15 USD | -7.14% |
| 2011 Q3 | -0.07 USD | 55.47% |
| 2011 Q4 | -0.32 USD | -379.04% |
| 2010 Q3 | -0.14 USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | -0.13 USD | 7.14% |
| Name | Eps | Eps Difference |
|---|---|---|
| Matricelf Ltd | -0.95 ILA | 99.368% |